4//SEC Filing
ENDOCYTE INC 4
Accession 0001144204-13-049208
CIK 0001235007operating
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 4:00 PM ET
Size
8.7 KB
Accession
0001144204-13-049208
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Ritter Allen R
VP of Manufacturing/CMC
Transactions
- Sale
Common Stock
2013-08-30$14.36/sh−6,000$86,160→ 17,722 total - Exercise/Conversion
Common Stock
2013-08-30$2.10/sh+6,000$12,600→ 23,722 total - Exercise/Conversion
Stock Option (right to buy)
2013-08-30−6,000→ 12,560 totalExercise: $2.10Exp: 2017-02-01→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]This option is fully vested and immediately exercisable.
- [F2]Represents the sale of 6,000 shares in multiple transactions, ranging in price from $14.26 to $14.45 per share, resulting in a weighted average sale price per share of $14.36. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
ENDOCYTE INC
CIK 0001235007
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001235007
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 4:00 PM ET
- Size
- 8.7 KB